ASX listing early seems locked in for early next year ahead of...

  1. qbiotics
    29 Posts.
    clock Created with Sketch.
    15/09/21
    12:22
    Post #: 56079901
    ASX listing early seems locked in for early next year ahead of scheduled announcement on preliminary results of human trials scheduled for July 22. Qbiotics has scheduled September 2024 for announcing full results of human combo trials of TT and Merck drug Keytruda. But unofficial word now is that Qbiotics "happy" with how the trials are going so far.
    Last edited by qbiotics: 15/09/21
    Likes Created with Sketch. 2  Upvote
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

GED Golden Deeps sniffs 80-metre-long copper and zinc sulphide zone at NSW's Havilah
right-arrow Created with Sketch.
PV1 Provaris updates on progress with Uniper under hydrogen MOU – not long after interesting ASX response
right-arrow Created with Sketch.
RBD Restaurant Brands posts record sales in half year report for FY24
right-arrow Created with Sketch.
SXG Southern Cross finds large gold-antimony zone underneath historic Victorian mine
right-arrow Created with Sketch.
STX Strike hits "significant" 28m of net gas pay downhole Australia's deepest ever gas well; extends system east
right-arrow Created with Sketch.
NEWS ASX explains: How 'futures' are predicted
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.